Suppr超能文献

5-羟色胺(5-HT)1A 和 5-HT2A 受体激动剂对大鼠程控反应的影响:药物联合研究。

Effects of serotonin (5-HT)1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: drug combination studies.

机构信息

Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA.

出版信息

Psychopharmacology (Berl). 2011 Feb;213(2-3):489-97. doi: 10.1007/s00213-010-2136-9. Epub 2010 Dec 21.

Abstract

RATIONALE

Indirect-acting serotonin (5-HT) receptor agonists (e.g., selective 5-HT reuptake inhibitors [SSRI]) stimulate multiple 5-HT receptors, although the role of particular receptors as well as interaction(s) among different receptors in the therapeutic effects of SSRIs is not fully understood.

OBJECTIVES

Relatively few studies have systematically examined direct-acting agonists in combination. This study examined the 5-HT(1A) receptor agonists 8-hydroxy-2-(di-n-propylamino) tetralin hydrochloride (8-OH-DPAT; 0.01-10.0 mg/kg) and 3-chloro-4-fluorophenyl-4-fluoro-4-([(5-methyl-6-methylamino-pyridin-2-ylmethyl)-amino]-methyl)-piperidin-1-yl-methanone (F13714; 0.01-1.0 mg/kg) and the 5-HT(2A) receptor agonists 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM; 0.32-10.0 mg/kg) and dipropyltryptamine (DPT; 1.0-32.0 mg/kg), alone and in combination, in rats responding under a fixed ratio schedule of food presentation.

RESULTS

When administered alone, each drug decreased the rate of responding in a dose-related manner with the potency order being F13714 > 8-OH-DPAT > DOM > DPT. WAY100635 (5-HT(1A) receptor antagonist; 0.01-0.1 mg/kg) attenuated the rate-decreasing effects of 8-OH-DPAT and F13714 while MDL100907 (5-HT(2A) receptor antagonist; 0.01-0.1 mg/kg) attenuated the rate-decreasing effects of DOM and DPT. Dose addition analysis showed that the interaction between 8-OH-DPAT and F13714, as well as the interaction between DOM and DPT, was additive. In contrast, the interaction between 8-OH-DPAT and DOM, as well as the interaction between F13714 and DOM, was infra-additive.

CONCLUSIONS

This study shows that for some dose combinations, agonist actions at one 5-HT receptor subtype attenuate agonist actions at another 5-HT receptor subtype; thus, the combined neuropharmacological actions and therapeutic effects of indirect-acting agonists are not likely to be adequately characterized by examining in isolation activity at particular 5-HT receptor subtypes.

摘要

背景

间接作用的 5-羟色胺(5-HT)受体激动剂(例如选择性 5-HT 再摄取抑制剂 [SSRIs])会刺激多种 5-HT 受体,但特定受体的作用以及 SSRIs 治疗效果中不同受体之间的相互作用尚不完全清楚。

目的

很少有研究系统地检查直接作用的激动剂的联合使用情况。本研究检测了 5-HT(1A)受体激动剂 8-羟基-2-(二正丙基氨基)四氢萘盐酸盐(8-OH-DPAT;0.01-10.0mg/kg)和 3-氯-4-氟苯基-4-氟-4-[[(5-甲基-6-甲基氨基-吡啶-2-基甲基)氨基]-甲基]-哌啶-1-基-甲酮(F13714;0.01-1.0mg/kg)以及 5-HT(2A)受体激动剂 1-(2,5-二甲氧基-4-甲基苯基)-2-氨基丙烷(DOM;0.32-10.0mg/kg)和二丙基色胺(DPT;1.0-32.0mg/kg),单独使用和联合使用时,在根据固定比率安排呈现食物的大鼠中,这些药物的作用减少了反应率。

结果

单独给药时,每种药物均以剂量相关的方式降低反应率,其效价顺序为 F13714>8-OH-DPAT>DOM>DPT。WAY100635(5-HT(1A)受体拮抗剂;0.01-0.1mg/kg)减弱了 8-OH-DPAT 和 F13714 的降低反应率作用,而 MDL100907(5-HT(2A)受体拮抗剂;0.01-0.1mg/kg)减弱了 DOM 和 DPT 的降低反应率作用。剂量相加分析表明,8-OH-DPAT 和 F13714 之间的相互作用以及 DOM 和 DPT 之间的相互作用是相加的。相比之下,8-OH-DPAT 和 DOM 之间的相互作用以及 F13714 和 DOM 之间的相互作用是次相加的。

结论

本研究表明,对于某些剂量组合,一种 5-HT 受体亚型的激动剂作用会减弱另一种 5-HT 受体亚型的激动剂作用;因此,间接作用的激动剂的联合神经药理学作用和治疗效果不太可能通过单独检查特定 5-HT 受体亚型的活性来充分描述。

相似文献

引用本文的文献

本文引用的文献

4
The 5-HT1A receptor and the stimulus effects of LSD in the rat.5-羟色胺1A受体与麦角酸二乙酰胺对大鼠的刺激作用。
Psychopharmacology (Berl). 2005 Oct;182(2):197-204. doi: 10.1007/s00213-005-0068-6. Epub 2005 Oct 19.
10
Some quantitative uses of drug antagonists.药物拮抗剂的一些定量应用。
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验